MedTrace Logo

Active Surveillance in Prostate Cancer

NCT00490763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1139

Last updated 2022-04-04

No results posted yet for this study

Summary

The goal of this clinical research study is to find out if men who have a type of prostate cancer that has been classified as "low risk" can safely not be treated for the disease. Doctors want to know if patients with "low risk" cancer can avoid or postpone therapy and the related side effects and still live as long as patients who immediately receive therapy.

This is an investigational study. There are no medications used in this trial.

About 1,000 patients will take part in this study. All will be enrolled at MD Anderson.

Conditions

Interventions

BEHAVIORAL

Survey

7 surveys at the beginning of the study and again every 6 months about diet, coping with the disease, and quality of life.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Christopher Logothetis, MD · M.D. Anderson Cancer Center

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-13
Primary Completion
2021-09-06
Completion
2021-09-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00490763 on ClinicalTrials.gov